Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells

BACKGROUND: The prognosis for patients with disseminated lung cancer is poor and current treatments have limited survival benefit as resistance often occurs, and is often associated with significant toxicity. A possible strategy to improve treatment and evade chemoresistance may be to find new combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sooman, Linda, Gullbo, Joachim, Bergqvist, Michael, Bergström, Stefan, Lennartsson, Johan, Ekman, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667477/
https://www.ncbi.nlm.nih.gov/pubmed/29096687
http://dx.doi.org/10.1186/s13104-017-2842-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667477/
https://www.ncbi.nlm.nih.gov/pubmed/29096687
http://dx.doi.org/10.1186/s13104-017-2842-z

Ejemplares similares